InspireMD, Inc. has entered into a public offering agreement that could significantly boost its financial resources. The company announced on November 13, 2026, that it aims to raise approximately $37.5 million through the sale of shares and warrants. This strategic move is essential for the company as it seeks to enhance its operations in the competitive surgical and medical instruments industry.

According to the filing, InspireMD will offer 7,342,308 shares of its common stock, along with pre-funded warrants to purchase up to 50,350,000 shares of common stock. Additionally, the offering includes Series L warrants to purchase up to 43,269,231 shares of common stock. The combined public offering price for the shares and accompanying warrants is set at $0.65 per share, while the pre-funded warrants will be priced at $0.6499.

InspireMD's decision to pursue this public offering comes at a time when the surgical and medical instruments sector is witnessing increased demand for innovative solutions. The funds raised will be utilized for various operational needs, including research and development, sales and marketing initiatives, and general corporate purposes.

As part of the underwriting agreement with Lake Street Capital Markets, the company has agreed to pay an underwriting discount of 6.0% of the gross proceeds from the offering. The agreement also includes provisions for the underwriters to cover over-allotments, allowing them to purchase additional shares if needed.

The filing indicates that the closing of the offering is expected to occur on or about November 16, 2026, pending the satisfaction of customary closing conditions. This timely capital infusion could enable InspireMD to accelerate its growth plans and remain competitive in the dynamic surgical and medical instruments market.

InspireMD, Inc. is a Delaware-based company focused on developing and commercializing innovative medical devices. The company trades on the Nasdaq under the ticker symbol NSPR and is categorized under the SIC code 3841, which pertains to surgical and medical instruments and apparatus.

The filing, with accession number 0001493152-26-051997, highlights the company's commitment to advancing its product offerings and expanding its market presence. As InspireMD moves forward with this public offering, it will be crucial to monitor how the additional capital will impact its operations and competitive positioning within the industry.